Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2012-05-08

Clinical Trial Update: Echocardiographically Guided Versus Standard Ibuprofen Treatment for Patent Ductus Arteriosus [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing echocardiography-guided ibuprofen dosing with standard ibuprofen treatment for patent ductus arteriosus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ibuprofen (IBUPROFEN)

Snippet

Sponsor: Fundacion para la Investigacion Biomedica del Hospital Universitario la Paz | Conditions: Patent Ductus Arteriosus | Phase 3 | Status: COMPLETED